首页> 外文会议>Computing in Cardiology Conference >Development and Validation of an In Silico Rabbit Purkinje Cell Action Potential Model: A Step Towards a Drug Safety Testing Tool
【24h】

Development and Validation of an In Silico Rabbit Purkinje Cell Action Potential Model: A Step Towards a Drug Safety Testing Tool

机译:In Silico兔浦肯野细胞动作电位模型的开发和验证:迈向药物安全测试工具的一步

获取原文

摘要

Companies and regulators evaluate compounds' cardiac safety commonly through in-vitro assays involving cardiac cells. Rabbit cardiac Purkinje Cells (RPCs) are very sensitive to drug effects such as Action Potential Duration (APD) alteration by ion channel block. Our objective is to create a novel RPC model calibrated with the latest experimental data. We developed a new RPC model using Pan-Rudy‘s Canine Purkinje cell model as a framework. We adapted important parameters, namely, size, ion fluxes and conductances. We also included a sodium current Markovian formulation to account for its recently increased importance. Variables were adjusted to match the main experimentally observed RPCs features. Steady-state was reached by pacing the model for 1500 seconds at different Basic Cycle Lengths (BCLs). The model was validated by extracting data from experimental sources. Results show overall agreement with the literature with improvements to previous models. In conclusion, we improved and successfully validated an RPC model. This work paves the way towards a reliable in-silico tool for testing drug effects on RPCs.
机译:公司和监管机构通常通过涉及心脏细胞的体外分析来评估化合物的心脏安全性。兔心脏浦肯野细胞(RPC)对药物作用非常敏感,例如通过离子通道阻滞改变动作电位持续时间(APD)。我们的目标是创建一个使用最新实验数据校准的新颖RPC模型。我们使用Pan-Rudy的Canine Purkinje细胞模型作为框架开发了一个新的RPC模型。我们调整了重要的参数,即尺寸,离子通量和电导率。我们还包括了当前的钠马尔可夫公式,以说明其最近的重要性。调整变量以匹配实验中观察到的主要RPC功能。通过在不同的基本周期长度(BCL)下对模型定步1500秒来达到稳态。通过从实验来源提取数据来验证该模型。结果表明,与以前的模型进行了改进后,与文献总体吻合。总之,我们改进并成功验证了RPC模型。这项工作为开发可靠的计算机内工具以测试药物对RPC的作用铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号